What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Enzyme
John J. Albers focuses on Internal medicine, Endocrinology, Cholesterol, Lipoprotein and Apolipoprotein B.
His study in Internal medicine is interdisciplinary in nature, drawing from both Acyltransferase and Hyperlipidemia.
The Cholesterol study combines topics in areas such as Human plasma, Chromatography and Apolipoprotein E.
His Lipoprotein study incorporates themes from Coronary heart disease, Polyacrylamide gel electrophoresis, Chronic hemodialysis and Myocardial infarction.
The concepts of his Apolipoprotein B study are interwoven with issues in Gene isoform, Radial immunodiffusion and Population sample.
He interconnects Simvastatin and Laropiprant in the investigation of issues within Niacin.
His most cited work include:
- Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial (2069 citations)
- Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B (2017 citations)
- Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary Disease (1797 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Endocrinology, Cholesterol, Lipoprotein and Apolipoprotein B.
His Internal medicine study integrates concerns from other disciplines, such as Hyperlipidemia and Cardiology.
His study in the field of Very low-density lipoprotein, Triglyceride and Low-density lipoprotein also crosses realms of Phospholipid transfer protein.
His biological study spans a wide range of topics, including Chromatography and Lecithin.
Lipoprotein is a subfield of Biochemistry that John J. Albers studies.
His Apolipoprotein B research is multidisciplinary, relying on both Radioimmunoassay and Radial immunodiffusion.
He most often published in these fields:
- Internal medicine (60.62%)
- Endocrinology (54.96%)
- Cholesterol (44.19%)
What were the highlights of his more recent work (between 2002-2019)?
- Internal medicine (60.62%)
- Phospholipid transfer protein (17.28%)
- Endocrinology (54.96%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Phospholipid transfer protein, Endocrinology, Lipoprotein and Cholesterol.
His research in Internal medicine focuses on subjects like Cardiology, which are connected to Gastroenterology and Homocysteine.
His work deals with themes such as Cerebrospinal fluid and Case-control study, which intersect with Endocrinology.
His work carried out in the field of Lipoprotein brings together such families of science as Diabetes mellitus, Computational biology and Bioinformatics.
His Cholesterol study focuses on High-density lipoprotein in particular.
The Apolipoprotein B study combines topics in areas such as Cellulose and Distribution.
Between 2002 and 2019, his most popular works were:
- Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: Recent Advances and Future Directions (219 citations)
- Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes). (181 citations)
- Phospholipid Transfer Protein Interacts with and Stabilizes ATP-binding Cassette Transporter A1 and Enhances Cholesterol Efflux from Cells * (136 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Enzyme
Internal medicine, Endocrinology, Phospholipid transfer protein, Lipoprotein and Cholesterol are his primary areas of study.
His research investigates the connection between Internal medicine and topics such as Cardiology that intersect with problems in Gastroenterology.
When carried out as part of a general Endocrinology research project, his work on Apolipoprotein B, Simvastatin and Low-density lipoprotein is frequently linked to work in Human brain, therefore connecting diverse disciplines of study.
His work in the fields of Apolipoprotein B, such as Lipoprotein, intersects with other areas such as Hazard ratio.
John J. Albers interconnects Diabetes mellitus, High-density lipoprotein and Serum samples in the investigation of issues within Lipoprotein.
His High-density lipoprotein research integrates issues from Acute coronary syndrome and Myocardial infarction.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
